Share

    


Home / Search Results

Search Results

You searched for:

ACCC conducted a comprehensive survey and a series of four focus groups to explore current attitudes, beliefs, and concerns related to multi-cancer early detection.
A mix-method approach to understand clinician use of biomarker testing for patients with non-small cell lung cancer.
As precision medicine becomes more common in the management of lung cancer, little is understood about the patient experience with biomarker testing, particularly of underserved patients. This study used survey and focus group methodology to determine patient perspectives on the educational needs within this community.
This ACCC education program shares key highlights from a national survey of thoracic surgeons, radiation oncologists, and medical oncologists on the barriers that exist in the ideal management of patients with NSCLC.
St. Vincent Hospital implemented a collaborative method of care that uses genetic counselor extenders to increase patient access to risk assessment and genetic testing.
Early identification, staging, and diagnosis of lung cancer is critical to improving patient outcomes. However, current diagnostic options are limited in accuracy, safety, and invasiveness—only 15 percent of patients with lung cancer are diagnosed at an early stage. Read how Fox Chase Cancer Center has implemented new flexible robotic endoscopic technology to diagnose hard-to-reach lung nodules with …
The Inherited Cancer Registry (ICARE) is an academic-community partnership among healthcare providers, researchers, and individuals at an increased risk for inherited cancer. Learn about ICARE’s research registry for high-risk individuals and education efforts on inherited cancer for both patients and providers.
This article describes molecular subtyping and shows how it is changing both the understanding of breast cancer and how to treat it. The article summarizes the most important new studies and details the impact of this new information for community cancer centers.
In 2013, ACCC proceeded with Phase II, Learning Labs for Process Improvement, a program for member institutions that focused on improving molecular testing at the system level through experiential learning labs.
The challenge providers face is to screen and detect “smarter” in order to minimize the burden of unnecessary biopsy and treatment. Ideally, the goal is to identify men who would benefit from aggressive therapy.